Skip to main content

Cardlytics, Inc.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

CDLX$1.63-10.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows (Unaudited)

Nine Months EndedSeptember 30,
20262025
Operating activities
Net loss$(28,303)$(95,238)
Adjustments to reconcile net loss to net cash used in operating activities:
Credit loss expense1,2041,782
Depreciation and amortization12,66119,039
Amortization of financing costs charged to interest expense9681,194
Amortization of right-of-use assets9421,789
Gain on divestiture(13,856)(4,831)
Stock-based compensation expense8,80822,617
Impairment of goodwill and intangible assets—58,843
Change in contingent consideration—102
Loss on investments2,387—
Other non-cash expense (income), net1,211(6,251)
Change in operating assets and liabilities:
Accounts receivable and contract assets, net21,07014,808
Prepaid expenses and other assets(1,107)(230)
Accounts payable(550)(193)
Other accrued expenses(4,488)1,762
Partner Share liability(10,544)(10,920)
Consumer Incentive liability(10,541)(7,993)
Net cash used in operating activities(20,138)(3,720)
Investing activities
Acquisition of property and equipment(50)(455)
Capitalized software development costs(6,531)(12,770)
Proceeds from sale of marketable securities, net23,029—
Business divestiture and acquisitions, net of cash acquired—200
Net cash provided by (used in) investing activities16,448(13,025)
Financing activities
Proceeds from issuance of debt15,00050,000
Settlement of contingent consideration—(5,000)
Principal payment of debt(30,070)(50,000)
Debt issuance costs(60)(105)
Net cash used in financing activities(15,130)(5,105)
Effect of exchange rates on cash and cash equivalents48217
Net decrease in cash and cash equivalents(18,772)(21,633)
Cash and cash equivalents — Beginning of period48,71965,594
Cash and cash equivalents — End of period$29,947$43,961

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

Nine Months EndedSeptember 30,
20262025
Supplemental disclosure of cash flow information:
Cash paid for interest$4,927$4,780
Amounts accrued for property and equipment$—$14
Amounts accrued for capitalized software development costs$27$141
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.